Clinical Pathway Leads to Drop in Total Abdominal Hysterectomies

Share this content:
Clinical Pathway Leads to Drop in Total Abdominal Hysterectomies
Clinical Pathway Leads to Drop in Total Abdominal Hysterectomies

MONDAY, Dec. 28, 2015 (HealthDay News) -- Following implementation of a hysterectomy pathway there has been a decrease in the proportion of total abdominal hysterectomy (TAH) procedures performed between 2012 and 2014, according to research published online Dec. 7 in Obstetrics & Gynecology.

Amin Sanei-Moghaddam, M.D., from the University of Pittsburgh School of Medicine, and colleagues conducted a retrospective medical record review to examine the effect of hysterectomy pathway implementation on the proportion of TAH procedures performed between fiscal years 2012 and 2014. All hysterectomy surgeries performed for benign indications at the University of Pittsburgh Medical Center were identified and analyzed by surgical approach, age, and indication of surgery. Data were included for 6,544 patients (mean age, 48.6 years).

The researchers found that 27.8 percent of the 1,934 hysterectomies performed as a result of noncancerous conditions in 2012 were TAH procedures. This percentage decreased to 22 percent in 2013 and to 17 percent in 2014. There was a significant decrease in the proportion of TAH procedures from 2012 to 2014 (P for trend < 0.001). The decreasing trend of TAH procedures persisted after adjustment for surgical indication (P for trend < 0.001).

"Implementation of a hysterectomy pathway has been associated with a decrease in the proportion of TAH hysterectomy procedures," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »